NKTX
Nkarta Inc
NASDAQ: NKTX · HEALTHCARE · BIOTECHNOLOGY
$2.69
-2.89% today
Updated 2026-04-29
Market cap
$201.75M
P/E ratio
—
P/S ratio
1,000,000.00x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$2 – $4
Volume
0.8M
Nkarta Inc (NKTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.18M | $-18.37M | $-43.51M | $-67.93M | $-57.00M | $-86.16M | $-99.70M | $-88.70M |
| Capital expenditures | $757880.00 | $1.93M | $7.51M | $5.03M | $47.11M | $28.15M | $4.41M | $1.21M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $182513.00 | $947000.00 | $6.75M | $14.46M | $16.86M | $17.20M | $16.73M | $8.56M |
| Free cash flow | $-5.94M | $-20.30M | $-51.02M | $-72.95M | $-104.11M | $-114.31M | $-104.11M | $-89.91M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $76.23M | $-34.19M | $-22.68M | — | — | — |